Company intelligence / Profile preview

Corvia Medical

Tewksbury, Massachusetts, United Statescorviamedical.com ↗

Ownership: Private
Employees: ~39
Development stage: Phase 3

Overview

Corvia Medical has developed the world’s first transcatheter atrial shunt device for treating HFpEF/HFmrEF. The REDUCE LAP-HF II pivotal study did not meet its primary endpoint overall but showed benefit in a narrower patient population. The ongoing RESPONDER-HF confirmatory trial aims to support FDA approval. Over three years of clinical data show favorable long-term effects on cardiac structure and function, and more than 675 patients have received the device across at least 18 countries.

Therapeutic areas: Cardiovascular
Modalities: Transcatheter structural heart devices (implantable shunt)
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Corvia Atrial Shunt

Phase 3

Indications: Heart failure with preserved ejection fraction, Heart failure with mildly reduced ejection fraction

Partnerships

Edwards Lifesciences—structural heart innovation agreement

Beyond the preview

Go deeper on Corvia Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corvia Medical.

Explore the full profile